Literature DB >> 837312

Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.

E Rossier, P H Phipps, J R Polley, T Webb.   

Abstract

The long-term effectiveness of rubella vaccination in childhood is particularly important because the ultimate goal of immunization is the prevention of infection during pregnancy. Of 25 healthy children tested 4 to 5 years after rubella vaccination, 19 showed no evidence of cell-mediated immunity (CM) to rubella virus despite the presence of hemagglutination-inhibition or complement-fixation antibodies or both. Twenty-two of 25 seropositive, naturally infected young adults showed evidence of CMI. These results indicate that fetuses of women who have been vaccinated against rubella may not be protected against damage by wild rubella infection during the pregnancy, when CMI is physiologically depressed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 837312      PMCID: PMC1879342     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  13 in total

1.  Whole-blood culture technique for functional studies of lymphocyte reactivity to mitogens, antigens, and homologous lymphocytes.

Authors:  J L Pauly; J E Sokal; T Han
Journal:  J Lab Clin Med       Date:  1973-09

2.  Suppression of the response of lymphocytes to phytohemagglutinin in rubella.

Authors:  L E McMorrow; T Vesikari; S R Wolman; J P Giles; L Z Cooper
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

3.  Impaired in vitro cell-mediated immunity to rubella virus during pregnancy.

Authors:  Y H Thong; R W Steele; M M Vincent; S A Hensen; J A Bellanti
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

4.  Development of specific cellular and humoral immune responses in children immunized with live rubella virus vaccine.

Authors:  R W Steele; S A Hensen; M M Vincent; D A Fuccillo; J A Bellanti
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

5.  Editorial: Rubella immunization: a five-year progress report.

Authors:  S Krugman; S L Katz
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

6.  Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States.

Authors:  S A Plotkin; J D Farquhar; P L Ogra
Journal:  JAMA       Date:  1973-08-06       Impact factor: 56.272

7.  Clinical studies with experimental live rubella virus vaccine (strain HPV-77). Evaluation of vaccine-induced immunity.

Authors:  H M Meyer; P D Parkman; T E Hobbins; F A Ennis
Journal:  Am J Dis Child       Date:  1968-06

8.  The relationship between rubella hemagglutination inhibition antibody (HIA) and rubella induced in vitro lymphocyte tritiated thymidine incorporation.

Authors:  K A Smith; L Chess; M R Mardiney
Journal:  Cell Immunol       Date:  1973-08       Impact factor: 4.868

9.  Controlling rubella: problems and perspectives.

Authors:  D M Horstmann
Journal:  Ann Intern Med       Date:  1975-09       Impact factor: 25.391

10.  Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers.

Authors:  C A Kauffman; J P Phair; C C Linnemann; G M Schiff
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

View more
  4 in total

Review 1.  Rubella vaccines: past, present and future.

Authors:  J M Best
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

2.  Rubella screening and immunization: its history and future-an ongoing challenge.

Authors:  T M Gerace
Journal:  Can Fam Physician       Date:  1987-01       Impact factor: 3.275

3.  Low level rubella immunity detected by ELISA and specific lymphocyte transformation.

Authors:  E Buimovici-Klein; A J O'Beirne; S J Millian; L Z Cooper
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

4.  Can we prevent an increase in the incidence of congenital rubella syndrome in the next decade?

Authors:  L Coulombe; W W Rosser
Journal:  Can Med Assoc J       Date:  1981-07-01       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.